Adenomyosis and infertility

article OA: green CC0
⚙ AI-generated deep summary by qwen3.7-flash, 2026-09-08 · read from full text ⓘ

This 2023 postgraduate thesis reviews literature from the last five years regarding the association between adenomyosis and infertility, specifically focusing on outcomes in women undergoing assisted reproductive technology. The analysis indicates that patients with adenomyosis generally experience lower clinical pregnancy and live birth rates compared to those without the condition, although this negative impact may be less pronounced in cases of mild to moderate disease severity. A significant limitation noted is the lack of a universal definition or classification system for the condition, which complicates diagnosis and comparative studies. This paper is centrally about adenomyosis — specifically its impact on fertility and assisted reproductive technology success rates.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Adenomyosis is a medical condition that affects a significant number of women around the world. It is identified by an abnormal growth of endometrial tissue within the muscle wall of the uterus. The exact cause of adenomyosis has not yet been scientifically proven, however several theories have been proposed. Clinical symptoms in patients affected by adenomyosis include abnormal uterine bleeding, dyspareunia, dysmenorrhea or infertility but one third of them may be without any symptoms. During the last years, adenomyosis has been identified as a condition found in young fertile-age women due to the recent advancements in imaging studies. Despite of that, a common definition and classification system are still lacking. Regarding the management and the treatment plan of adenomyosis, there are medical as well as surgical options. The medical therapies for adenomyosis aim to treat local hyperestrogenism and alleviate the most severe symptoms of adenomyosis. Adenomyosis has also been significantly associated with an increased risk of obstetric complications and negative effects on fertility after assisted reproductive technology. This study reviewed the articles about adenomyosis and infertility published in PubMed in the last five years. Women with adenomyosis undergoing assisted reproductive technology treatment, have been found to have lower clinical pregnancy rates and live birth rates compared to women without adenomyosis. However, the impact of adenomyosis on IVF outcomes may be dependent on the severity and extent of the disease, with some studies reporting that patients with mild to moderate adenomyosis may not experience significant reductions in IVF success rates. The optimal management strategy for women with adenomyosis undergoing IVF remains controversial, and further research is needed to determine the most effective treatment options for this patient population.
Full text 5,282 characters · extracted from oa-html · click to expand
| Home > Theses > PostGraduate Theses > Adenomyosis and infertility | | PostGraduate Theses | GRI-2023-39862 | | Title: | Adenomyosis and infertility Αδενομύωση και υπογονιμότητα | | Authors: | Ζαφειράτη Χριστιάνα Οδυσσέα | | Postgraduate Program Title: | Εφαρμογή ενδοσκοπικών χειρουργικών τεχνικών στη γυναικολογία (Διατμηματικό ΠΜΣ) | | Department: | Αριστοτέλειο Πανεπιστήμιο Θεσσαλονίκης, Σχολή Επιστημών Υγείας, Τμήμα Ιατρικής Κτηνιατρικής | | Language: | English | | 2023 | | | Adenomyosis is a medical condition that affects a significant number of women around the world. It is identified by an abnormal growth of endometrial tissue within the muscle wall of the uterus. The exact cause of adenomyosis has not yet been scientifically proven, however several theories have been proposed. Clinical symptoms in patients affected by adenomyosis include abnormal uterine bleeding, dyspareunia, dysmenorrhea or infertility but one third of them may be without any symptoms. During the last years, adenomyosis has been identified as a condition found in young fertile-age women due to the recent advancements in imaging studies. Despite of that, a common definition and classification system are still lacking. Regarding the management and the treatment plan of adenomyosis, there are medical as well as surgical options. The medical therapies for adenomyosis aim to treat local hyperestrogenism and alleviate the most severe symptoms of adenomyosis. Adenomyosis has also been significantly associated with an increased risk of obstetric complications and negative effects on fertility after assisted reproductive technology. This study reviewed the articles about adenomyosis and infertility published in PubMed in the last five years. Women with adenomyosis undergoing assisted reproductive technology treatment, have been found to have lower clinical pregnancy rates and live birth rates compared to women without adenomyosis. However, the impact of adenomyosis on IVF outcomes may be dependent on the severity and extent of the disease, with some studies reporting that patients with mild to moderate adenomyosis may not experience significant reductions in IVF success rates. The optimal management strategy for women with adenomyosis undergoing IVF remains controversial, and further research is needed to determine the most effective treatment options for this patient population. Η αδεονομύωση αποτελεί μια ιατρική πάθηση που επηρεάζει ένα μεγάλο ποσοστό γυναικών στον κόσμο. Χαρακτηρίζεται από την ανάπτυξη ενδομήτριου ιστού στο μυομήτριο. Η ακριβής αιτία παθογένειας της νόσου δεν έχει ακόμα αποδειχτεί, όμως έχουν προταθεί μερικές επιστημονικές θεωρίες στη διεθνή βιβλιογραφία. Τα κλινικά συμπτώματα της νόσου αποτελούν η ανώμαλη κολπική αιμόρροια, η δυσπαρεύνια, η δυσμηνόρροια ή υπογονιμότητα , όμως το ένα τρίτο των ασθενών δύναται να παραμένουν ασυμπτωματικές. Κατά τη διάρκεια των τελευταίων ετών, η αδενομύωση συναντάται σε γυναίκες μικρής αναπαραγωγικής ηλικίας εξαιτίας της τεχνολογικής εξέλιξης των διαγνωστικών μέσων. Ωστόσο, δεν υπάρχει ένα ενιαίο παγκόσμιο μοντέλο σταδιοποίησης και διάγνωσης. Υπάρχουν φαρμακευτικές και χειρουργικές επιλογές για την αντιμετώπιση της αδενομύωσης. Οι φαρμακευτικές δρουν αντιρροπιστικά στην τοπική υπεροιστρογοναιμία που προκαλείται από την αδενομύωση, αντιμετωπίζοντας τα έντονα κλινικά συμπτώματα που προκαλούνται λόγω αυτής. Η αδενομύωση έχει συσχετιστεί με αυξημένο κίνδυνο μαιευτικών επιπλοκών στην κύηση, καθώς και με αρνητική επίδραση στη γονιμότητα ύστερα από χρήση μεθόδου υποβοηθούμενης αναπαραγωγής. Αυτή η μελέτη συνιστά μια ανασκόπηση της βιβλιογραφίας των τελευταίων πέντε ετών στην επιστημονική βάση του PubMed. Προκύπτει ότι οι γυναίκες με αδενομύωση που υπεβλήθησαν σε μέθοδο υποβοηθούμενης αναπαραγωγής, είχαν λιγότερα ποσοστά επίτευξης εγκυμοσύνης και γέννησης , συγκριτικά με τις γυναίκες που δεν είχαν τη νόσο. Ωστόσο το μέγεθος της επίδρασης της αδενομύωσης στα αποτελέσματα της υποβοηθούμενης αναπαραγωγής μπορεί να εξαρτάται από το στάδιο της νόσου , καθώς υπάρχουν μελέτες που υποστηρίζουν ότι οι γυναίκες με ήπια αδενομύωση δεν έχουν μικρότερο ποσοστό επίτευξης εγκυμοσύνης με μέθοδο υποβοηθούμενης αναπαραγωγής, από αυτές που δεν έχουν αδενομύωση. Ο αποτελεσματικότερος τρόπος αντιμετώπισης της αδενομύωσης σε γυναίκες που υποβάλλονται σε υποβοηθούμενη αναπαραγωγή, παραμένει αμφιλεγόμενος. Ως εκ τούτου, περισσότερες μελέτες χρειάζονται ώστε οι γυναίκες με αδενομύωση να έχουν καλύτερες επιλογές στην αντιμετώπιση της υπογονιμότητας . | | | Supervisor: | Δανιηλίδης, Άγγελος, αναπλ. καθ. | | Advisory / Examination Committee: | Σαρδέλη, Χρυσάνθη, επίκ. καθ. Νταφόπουλος, Κωνσταντίνος , καθ. | | Defense Date: | 01/06/2023 | | Keywords: | Υποβοηθούμενη αναπαραγωγή, Υπογονιμότητα, Infertility, Αδενονύωση, Assisted reproductive technology, Adenomyosis | | DOI: | 10.26262/heal.auth.ir.349138 | | Related files: | Fulltext: PDF File with license: | | Access Restrictions: | Embargo restrictions apply to the fulltext. At the author's request, the full text of this work will be publicly available for download after 1/7/2026. | Record created 2023-07-03, last modified 2023-08-01 - Add to personal basket - Export as BibTeX, MARC, MARCXML, DC, EndNote, NLM, RefWorks - Send to Mendeley - Share via:

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-html ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

adenomyosisdysmenorrheadyspareuniainfertility

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-05-11T03:52:31.725103+00:00
License: CC0 · commercial use OK